________________________________________________________________________________________________________________________
“ Valued at approximately $ 134m – Mölnlycke’ s largest investment to date – the project is a multi-phase expansion of Mölnlycke’ s US wound care manufacturing campus. The development will include 79,000 square feet of new construction and a complete renovation and modernization of the existing 64,000-square-foot manufacturing facility. With the expansion of the warehouse and clean manufacturing space, we’ re implementing new production lines, offices, warehouses, and support spaces.
“ This project is strategically important for both organizations. For Mölnlycke, it increases US manufacturing capacity for advanced wound care products, strengthens domestic supply chains, supports long-term sustainability initiatives through renewable energy systems, including solar and wind power. For us, this project demonstrates our ability to manage complex pharmaceutical and medical manufacturing facilities, expanding our portfolio in the life sciences and advanced manufacturing sectors. Alongside that, it reinforces our longstanding relationships with repeat clients who value collaboration, planning, and execution.”
Disiciplined execution
From landmark educational facilities and innovative higher education spaces to advanced manufacturing and life sciences projects, Landry / French continues to demonstrate that a strong culture, engaged employee-owners, and a commitment to excellence are the foundation for long-term success. With a clear vision for the next chapter, the company remains focused not just on building more than exceptional structures, but a legacy of trust, partnership, and positive
112